MAYNE PHARMA GROUP LIMITED - Announcements

Market Cap $393.8M Add to my watchlist

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

MYX	Preliminary Final Report	PRICE SENSITIVE	31/08/11	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	05/07/11	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	15/06/11	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/11	Share
MYX	Future Cash Flow Reporting	PRICE SENSITIVE	01/02/11	Share
MYX	Mayna Pharma Files SUBACAP for Registration in the EU	PRICE SENSITIVE	17/12/10	Share

MYXPreliminary Final Report
31/08/11	PRICE SENSITIVE	Share
MYXMayne Pharma Market Update
05/07/11	PRICE SENSITIVE	Share
MYXMayne Pharma Market Update
15/06/11	PRICE SENSITIVE	Share
MYXHalf Yearly Report and Accounts
25/02/11	PRICE SENSITIVE	Share
MYXFuture Cash Flow Reporting
01/02/11	PRICE SENSITIVE	Share
MYXMayna Pharma Files SUBACAP for Registration in the EU
17/12/10	PRICE SENSITIVE	Share

REFRESH

First

(20min delay)
Last $4.48		Change 0.300(7.18%)		Mkt cap ! $393.8M

Open	High	Low	Value	Volume
$4.22	$4.50	$4.18	$1.134M	259.5K

Buyers (Bids)

No.	Vol.	Price($)
1	708	$4.43

Sellers (Offers)

Price($)	Vol.	No.
$4.50	1182	1

View Market Depth

No.	Vol.	Price($)
1	383	4.670
1	668	4.640
1	668	4.630
1	668	4.620
1	668	4.610

Price($)	Vol.	No.
4.740	668	1
4.750	668	1
4.760	668	1
4.770	668	1
4.780	668	1

Last trade - 16.10pm 22/11/2024 (20 minute delay)


Last $4.48		Change 0.300 ( 7.09 %)
Open	High	Low	Volume
$4.23	$4.49	$4.17	95547
Last updated 15.59pm 22/11/2024 ?

MYX (ASX) Chart